Medicaid Health Plans of America has a new president and CEO.
Integrated healthcare and payment reform are two efforts of Medicaid Health Plans of America (MHPA) under its new president and CEO, government affairs veteran Jeff Myers. Myers has succeeded Joe Moser, MHPA’s interim executive director and director of government affairs, who was recently appointed Medicaid Director of Indiana.
“What has become my entrance is how healthcare will eventually become fully integrated in the United States, and provide real value to the folks who are accessing it. Right now, it’s all fragmented,” Myers says. “Insurance has the opportunity to integrate everything.”
Myers, whose presidency began earlier this month, leaves behind his title of senior vice president of policy and government relations at the American Health Care Association.
He says MHPA is an organization that is in the right space at the right time.
“For MHPA, it’s a chance to look at how that integration is going to occur, particularly in managing the Medicaid population-with both the expansion of the ACA and the needs of those subpopulations in Medicaid, which tend to be more challenging than commercial insurance,” he says.
The board wanted to bring someone on that could make the organization a go-to for the issues facing the Medicaid population and the insurers that service it, he says. They predict MHPA will grow in size over the next few years based on where it’s positioned in the industry.
“The real vision is to become a leader to the folks here at the federal level, and also at the state level, that are grappling with how to provide real value to the populations they insure, while simultaneously making sure tax payers are getting the value of their dollar,” he says. “Several years out, if we’re successful, I think MHPA is really going to have an opportunity to bring a lot of the knowledge their members have to decision makers so that decisions are made well moving into the future.”
He says former MHPA CEO Thomas Johnson laid the foundation of the organization well, and he can only continue to build on its future.
“This is the time where Medicaid matures from a fee-for-service, anything-goes unmanaged population,” he says. “Notwithstanding the rollout problems that the ACA has had, folks really believe that in the next couple of years we’re going to see a giant fee change in this environment.”
At MHPA’s annual meeting in October, Myers says the general outlook on payment reform was a positive one, which he was not expecting.
“I thought I’d find people that were nervous, but everyone seemed to say that if only we could do this, we’d provide better value,” he says. “That’s an exciting place to be.”
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
Air Pollution May Negatively Affect Male Reproductive Health
November 30th 2023A potential mechanism by which air pollutants may affect reproductive health is by endocrine disruption. Air pollutants are made up of mixtures of particulate matter that may include endocrine disruptors, such as polycyclic aromatic hydrocarbons (PAHs) and heavy metals.
Read More
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More